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Abstract
Background: Ruminant mycoplasmoses are important diseases worldwide and several are listed by the World 
Organization for Animal Health to be of major economic significance. In France the distribution of mycoplasmal 
species isolated from clinical samples collected from diseased animals upon veterinary request, is monitored by a 
network known as VIGIMYC (for VIGIlance to MYCoplasmoses of ruminants). The veterinary diagnostic laboratories 
collaborating with VIGIMYC are responsible for isolating the mycoplasmas while identification of the isolates is 
centralized by the French Food Safety Agency (AFSSA) in Lyon. The VIGIMYC framework can also be used for specific 
surveys and one example, on the prevalence of M. bovis in bovine respiratory diseases, is presented here.
Results: Between 2003 and 2008, 34 laboratories were involved in the network and 1904 mycoplasma isolates, 
originating from the main ruminant-breeding areas, were identified. For cattle, the high prevalence of M. bovis in 
bronchopneumonia, notably in young animals, was confirmed by VIGIMYC and an associated specific survey, whereas 
the non-emergence of species such as M. alkalescens and M. canis was also demonstrated. The etiological agent of 
bovine contagious pleuropneumonia was never isolated. The principal mycoplasmosis in goats was contagious 
agalactia with M. mycoides subsp. capri as main agent. Ovine mycoplasmoses, most of which were associated with 
pneumonia in lambs, were infrequently reported. One exception was ovine contagious agalactia (due to M. agalactiae) 
that has recently re-emerged in the Pyrénées where it had been endemic for years and was also reported in Corsica, 
which was previously considered free.
Conclusions: Although VIGIMYC is a passive network and somewhat biased as regards sample collection and 
processing, it has provided, in this study, an overview of the main mycoplasmoses of ruminants in France. The French 
epidemiological situation is compared to those existing elsewhere in the world.
Background
The name "mycoplasma" is conventionally used to desig-
nate Mollicutes, a class of bacteria that lack a cell wall and
have often been portrayed as "minimal self-replicating
organisms" because of their small genome size and the
paucity of their metabolic pathways. More than 200 spe-
cies have been identified to date, amongst which are
severe pathogens of humans, animals and plants.
Approximately 40 mycoplasma species have so far been
described in domestic ruminants (cattle, sheep and
goats). Some of them are pathogenic and 3 mycoplasma-
induced diseases are currently listed by the World Orga-
nization for Animal Health (OIE) to be of major eco-
nomic importance. The first is contagious bovine
pleuropneumonia (CBPP) of which the causal agent is
Mycoplasma (M.) mycoides subsp.  mycoides  biotype
Small Colony (MmmSC). CBPP was once a major panzo-
otic disease of cattle and is still of consequence in Africa
and parts of Asia [1]. Europe has been considered CBPP-
free since the beginning of the 20th century despite some
localized resurgences [2,3]. The second is contagious
caprine pleuropneumonia (CCPP) caused by M. capri-
colum subsp. capripneumoniae (Mccp), a disease that is
still rife in Africa and the Middle East [4,5] and has more
recently been identified along eastern European borders
[6] and in captive wildlife [7]. The third is contagious aga-
lactia (CA) a cosmopolitan disease that affects small
ruminants and is a serious threat to dairy production in
the Mediterranean basin [8]. The CA syndrome takes
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many clinical forms (mastitis, arthritis, pneumonia and
septicemia) and is caused by several Mycoplasma species:
M. agalactiae affects sheep and goats, while mycoplas-
mas in the spiroplasma group, consisting of M. mycoides
subsp. capri (Mmc) (including the former M. mycoides
subsp. mycoides Large Colony [9]), M. capricolum subsp.
capricolum (Mcc) and M. putrefaciens mainly affect goats.
Another mycoplasmosis in cattle, in which M. bovis is the
causal agent, is not on the OIE list but is considered to
intensify concomitantly with animal production and
international trade. It is associated with a variety of clini-
cal expressions [10], notably infectious bronchopneumo-
nia (IBP) in young animals, as previously reported in
France [11] and several other countries [12-16].
Increased interest has recently been shown in monitor-
ing mycoplasma incidence and distribution to assess the
risks of introduction, emergence, resurgence or intensifi-
cation of these economically and/or statutorily important
diseases. The United Kingdom is the only European
country to have set up a national surveillance network
and regularly publishes prevalence results ([16], see also
the website http://www.defra.gov.uk/vla/reports/
rep_surv.htm). The epidemiological status of other Euro-
pean countries can only be inferred from fixed-term sur-
veys (see for instance [12,17,18]). However the
coexistence of distinct situations throughout Europe has
been documented. For example, the UK is free of all
mycoplasmoses listed by the OIE [16] whereas CA is
widespread in southern Europe [8].
Since 2003, France has been managing a national epide-
miological surveillance network known as VIGIMYC, the
aim of which is to determine which mycoplasmas are the
usual etiological agents of ruminant diseases. Special
emphasis is placed on CBPP, mainly because the persis-
tence of MmmSC in Europe cannot be definitely excluded
after the last unexpected and atypical CBPP resurgences
that occurred in the 1990's in southwestern Europe,
including France [2]. The VIGIMYC operating proce-
dures have been adapted to detect the European form of
CBPP, i.e. poorly virulent and immunogenic strains
[19,20]. Moreover, because the CBPP agent had been iso-
lated from small ruminants in Africa, Asia and Europe
[21-23], these have been considered as potential reser-
voirs and included in the surveillance strategy.
This article describes the VIGIMYC operating proce-
dures and the principal data obtained between 2003 and
2008. The results of a survey, concerning the relative
importance of mycoplasmoses in bovine pneumonia and
conducted over a shorter period within the VIGIMYC
framework, are also presented. A critical analysis of the
derived epidemiological picture is proposed which takes
into account the surveillance methodology and data from
other countries.
Methods
VIGIMYC operating procedures
VIGIMYC is managed by the French Food Safety Agency
(AFSSA) in Lyon under the guidance of a steering com-
mittee that includes representatives from partner-labora-
tories, public authorities, veterinarians, farmers and
scientists. The day-to-day functioning of this centralized
and passive network depends on several protagonists.
Whenever the veterinary practitioner in charge of a herd
suspects a mycoplasmosis, clinical specimens are sam-
pled and sent to a local laboratory for mycoplasma cul-
ture. Information about the clinical case is attached to
each sample. If a mycoplasma is isolated, the culture is
sent to the AFSSA laboratory for identification of the iso-
lates, which requires special procedures and cannot rely
on biochemical characterization, unlike more common
bacteria [24]. The results of mycoplasma identification
are sent back to the local laboratory and forwarded to the
veterinary practitioner. All identification results, together
with a description of the clinical cases, are registered in
an AFSSA database.
Survey of incidence of mycoplasmosis in cattle respiratory 
diseases
In 2008 a questionnaire was sent to all VIGIMYC part-
ner-laboratories to assess the number of clinical speci-
mens from bovine respiratory diseases received per year
and the number of such specimens that were seeded for
bacteria and/or mycoplasma detection. A total of 23 labo-
ratories answered the questionnaire for the 2006-2007
period and the number of samples specifically positive for
M. bovis was determined.
Isolation and identification of isolates
The isolation [25] and culture [24] of mycoplasmas were
performed as previously described. Both broth and agar
cultures were sent to AFSSA for identification purposes.
The isolates were identified by dot immunoblotting on
a filtration membrane [26]. Each isolate was tested on
specific hyperimmune sera prepared from reference
strains of the 11 most commonly isolated ruminant
mycoplasmas and a specific MmmSC monoclonal anti-
body [27]. In the event of an ambiguous or negative
response to all sera, further assays were conducted using
species-specific PCR and/or house-keeping genes
s e q u e n c i n g ,  m a i n l y  1 6 S  r D N A  [ 2 8 ]  b u t  a l s o  fusA for
strains belonging to the "M. mycoides" group [29,30].
Results
During the 2003-2008 period, 34 laboratories located in
the main ruminant-breeding areas (see Fig. 1 and 2, for
cattle and goats, respectively) took part in the network.
Clinical specimens were collected from 1312 outbreaks in
64 French departments. A total of 1904 isolates were cul-Chazel et al. BMC Veterinary Research 2010, 6:32
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tured by local laboratories and sent to AFSSA for identifi-
cation. These were respectively from cattle (56%), goats
(32%), sheep (8%) and wildlife (4%). Most of the 1904 iso-
lates were unambiguously identified by MF-dot immu-
nobinding assays - the technique used for routine
mycoplasma identification in the laboratory; see Methods
section- and only about forty had to be analyzed further
by PCR or sequence analysis to ensure accurate identifi-
cation.
The overall results are summarized in Table 1. As a
general rule 1) the number of mycoplasmal cultures
received at AFSSA differs from the number of strains
identified, this corresponding to a balance between sam-
ples containing several strains and negative samples; 2)
each outbreak can be represented by one or several cul-
tures as a function of its importance; and 3) each diseased
wildlife animal was considered as an outbreak per se.
Cattle
A total of 857 outbreaks in cattle were documented,
stemming from 64 departments (Fig. 1), and 1061 cul-
tures were received at AFSSA. Most of these cultures
originated from animals with respiratory disease (83%)
and from young animals (70%). Mastitis, arthritis or otitis
only accounted for 4% of the cultures, while the clinical
history was not documented for another 13%. In all, 1142
mycoplasma strains belonging to ten species were identi-
fied (see Table 1), the most frequent being M. bovis (55%),
which was often (12%) mixed with other mycoplasma
species, mainly M. bovirhinis and  M. arginini. Seven
other species were identified occasionally, including spe-
cies for which cattle is not the usual host, e.g. M. canis,
Mmc  or  M.agalactiae. The etiological agent of CBPP,
MmmSC, was never isolated.
In 2006/2007, a specific survey was conducted within
the VIGIMYC framework (for details, see Methods sec-
tion). This survey revealed that the possible mycoplasmal
etiology of bovine respiratory diseases had been fre-
quently investigated in France and confirmed the place of
M. bovis as a major bovine pathogen. In all 2020 bovine
samples were collected from respiratory diseases and
Figure 1 Distribution of bovine breeding areas in France and origin of mycoplasmal cultures sent to AFSSA for identification. The color code 
of each department indicates the number of bovines present in this department in 2008 (Agrest 2008, http://agreste.agriculture.gouv.fr). The yellow 
circles indicate the number of mycoplasmal cultures originating from each department over the 2003-2008 period. Note that 63 of the 1061 cultures 
collected are not represented on the map because the indicated origin was ambiguous.Chazel et al. BMC Veterinary Research 2010, 6:32
http://www.biomedcentral.com/1746-6148/6/32
Page 4 of 8
analysed in the 23 participating laboratories. Of these,
1557 (75%) were tested for the presence of mycoplasmas,
approximately 25% (378/1557) were found positive and
15% (240/1557) specifically contained M. bovis.
Goats
A total of 611 samples from 45 departments (Fig. 2) were
received at AFSSA. Most were associated with CA out-
breaks (268 documented outbreaks) but some were col-
lected from bulk tank milk controls (25%). In all, 664
strains were identified belonging to eight species (see
Table 1), the most frequent being Mmc (42%), Mcc (26%)
and M. putrefaciens (15%). M. agalactiae was the main
etiological agent in only 10 of the 268 CA outbreaks (dis-
tributed across 6 departments). M. arginini was rarely
identified (8% of all strains) and mainly in association
with pneumonic pasteurellosis in kids. M. yeatsii, a usual
commensal of the ear canal, was isolated once from a
milk tank and once in a case of septicemia.
Sheep
A total of 113 outbreaks, mainly of respiratory diseases in
lambs, occurred in 36 departments and 158 cultures were
received at AFSSA. The most frequently identified myco-
plasma was M. arginini (67%) while recovery of Mmc and
M. ovipneumoniae was poor. Since 2002, ovine CA due to
M. agalactiae in France had been only detected in the
Pyrénées-Atlantiques department. Historically, this is a
major area of endemic ovine CA. However, the depart-
ment did not take part in VIGIMYC during the 2003-
2008 period and therefore most of the CA outbreaks (up
to 135 in 2008) were detected by systematic PCR screen-
ing of tank milk. Nevertheless, two new CA outbreaks
were documented in Corsica in 2008, thanks to
VIGIMYC.
Wildlife
An abnormal increase in mortality, with lesions of severe
bronchopneumonia and keratoconjunctivitis, was
observed incidentally in certain ibex (Capra ibex) popu-
Figure 2 Distribution of goat-breeding areas in France and origin of mycoplasmal cultures sent to AFSSA for identification. The color code 
of each region (a group of departments delineated by a white line) indicates the number of goats present in this region in 2008 (Agrest 2008, http://
agreste.agriculture.gouv.fr). The yellow circles indicate the number of mycoplasmal cultures originating from each department over the 2003-2008 
period. Note that 96 of the 611 isolates collected are not represented on the map because the indicated origin was ambiguous and one because it 
originated from an overseas French department.Chazel et al. BMC Veterinary Research 2010, 6:32
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lations in the Alps. In addition to common bacterial
agents of pneumonia, M. agalactiae was regularly iso-
l a t e d  f r o m  d e e p  l u n g  t i s s u e  l e s i o n s  i n  t h e s e  a n i m a l s .
Mycoplasmas from the Mmc taxon were also frequently
isolated but mainly from the usual body sites of carriage
such as the ear canals.
Discussion
VIGIMYC operating procedures
T h i s  o v e r v i e w  o f  r u m i n a n t  m y c o p l a s m o s e s  i n  F r a n c e
over six years cannot be considered exhaustive due to
several biases introduced by the VIGIMYC design. Firstly,
an investigation for mycoplasmas in a clinical specimen is
only carried out by laboratories if explicitly requested by
the veterinary practitioners. This request is influenced
both by the veterinarian's awareness of mycoplasmoses
and by financial considerations. In an attempt to limit
these biases AFSSA regularly organizes information ses-
sions about mycoplasmas in ruminants and provides free
identification of pre-cultured mycoplasmas. The fact that
the detection of mycoplasmas is dependent on a cultiva-
tion step introduces another bias since non-cultivable
mycoplasmas, such as hemoplasmas [31], or fastidious
ones are missed. For example, M. dispar is potentially
pathogenic for cattle [32] but cannot be grown on the cul-
ture media commonly used in laboratories, neither can
Mccp, the etiological agent of CCPP, a disease currently
absent from France. In addition, when several myco-
plasma species are present in one sample (as was the case
for 16% and 13% of the goat and cattle samples, respec-
tively, analyzed here), the cultivation step tends to favor
the most rapidly-growing species to the detriment of the
slower growing but often pathogenic ones. Typically, 2
mycoplasma species, M. bovirhinis and M. arginini, were
frequently isolated from cattle and from all ruminants,
respectively, but their presence in a sample is of no diag-
nostic significance since their pathogenicity has never
been established [33,34]. However, in sheep, M. arginini
Table 1: Number and distribution of ruminant mycoplasma species, identified by VIGIMYC between 2003 and 2008.
Ruminant hosts
(total number of strains)
Cattlea
(1142)
Goatsb
(664)
Sheepc
(137)
Ibexd
(61)
Mycoplasma species recovered N % N % N % N
M. bovis 628 55 - - - - -
M. agalactiae 1 0.1 13 2 28 20.4 11
M. bovirhinis (o) 314 27.5 - - 1 0.7 -
M. canis (p ?) 2 0.2 - - - - -
M. arginini (o ?) 162 14.1 65 10 92 67.1 4
M. alkalescens (p ?) 14 1.2 - - - - -
M. canadense (p ?) 5 0.4 - - - - -
M. bovigenitalium (o) 4 0.4 - - 1 0.7 -
M. mycoides subsp. capri 4 0.4 281 42.3 6 4.4 43
M. mycoides subsp. mycoides SC - - - - - - -
M. capricolum subsp. capricolum - - 175 26.3 - - -
M. leachii - - - - - - -
M. putrefaciens - - 104 15.5 - - -
M. yeatsii (o) - - 24 3.5 - - -
M. ovipneumoniae (p ?) - - 1 0.2 8 6 -
M. auris (o) - - - - - - 3
M. conjunctivae - - 1 0.2 - - -
Acholeplasma laidlawii (o) 8 0.7 - - 1 0.7 -
Species for which the pathogenicity is unknown (p?) or that are opportunists (o) or putative opportunists (o?) are indicated. N = number of 
strains identified for each species. % = percentage of strains belonging to a mycoplasmal species in relation to the total number of 
mycoplasmal strains isolated from each farm species. - = zero.
a) Cattle: 1061 cultures were received from 857 outbreaks, of which 61 were negative (no mycoplasma or contamination by bacterial or fungi)
b) Goats: 611 cultures were received from 268 outbreaks, of which 45 were negative.
c) Sheep: 158 cultures were received from 113 outbreaks, of which 28 were negative.
d) Ibex: 74 cultures were received from ibex, of which 13 were negative.Chazel et al. BMC Veterinary Research 2010, 6:32
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may mask the existence of a pathogenic slow-growing
species like M. ovipneumoniae. Last but not least, as
explained in detail in a previous study [24], the antigenic
identification of mycoplasmas by MF-dot can be ambigu-
ous. Additional identification procedures were notably
helpful when mycoplasma species were recovered from
unexpected hosts. Recently, the strict host-specificity of
several mycoplasmas, such as MmmSC, M. agalactiae, M.
bovis and Mcc [35,36] has been increasingly questioned
and notably, in the present study, cattle were found host-
ing Mmc and M. agalactiae.
Despite these biases, VIGIMYC provides an informa-
tive overview of the epidemiological situation in France
for the most commonly found ruminant pathogenic
mycoplasmas.
High prevalence of M. bovis infections
The VIGIMYC data and results from the associated sur-
vey both confirmed the high prevalence in France of M.
bovis in IBP as previously demonstrated for young ani-
mals [11]. A comparable situation exists in several coun-
tries [12-16] although the reported bronchopneumonia
infection rates appear to vary considerably with rearing
conditions in the different studies. In Europe, Finland,
that remains free of M. bovis, is a notable exception [17].
However, because M. bovis was associated with other
pathogenic bacteria in 70% of the clinical cases in the
VIGIMYC results (data reported by partner laboratories),
its etiological implication has yet to be clarified. M. bovis
alone was shown to produce lung lesions, under experi-
mental conditions, even in gnotobiotic calves [34] and
was seldom isolated from healthy animals in herds
[12,37]. Furthermore M. bovis appears to initiate the
infectious process [11] and causes chronic bronchopneu-
monia with typical caseous necrosis. Because this infec-
tion is persistent and poorly responsive to antibiotics it is
undoubtedly one of the most economically deleterious
forms of M. bovis infection [13,15].
Other clinical forms of M. bovis infection such as
arthritis, mastitis and otitis, were infrequently reported
by VIGIMYC but may be worrisome in other countries
[14,38]. Arthritis was often associated with IBP and a few
epizooties of arthritis alone in young animals, with unfa-
vorable prognosis, were documented. In addition, the
first French case of M. bovis otitis in calves was detected
in 2008.
Other mycoplasma infections in cattle
M. canis and M. alkalescens, suspected to cause emerging
epizootic diseases in UK cattle [16,39] were rarely
reported by VIGIMYC. M. canis, a usual host of the
canine genital tract, was isolated from cattle for the first
time in 1993 in the Netherlands [40]. By 1999, it repre-
sented 12% in Belgium [12] and 18% in the UK [16] of all
mycoplasmas isolated from calves with IBP. Its pathoge-
nicity for cattle under experimental conditions is equivo-
cal [41,42]. During the six years covered by this report, M.
canis was only twice isolated in France. A retrospective
study on collection of the AFSSA strains was conducted
because of a suspected misidentification between the
closely related M. canis and M. bovirhinis species. This
misidentification was confirmed and three M. canis
strains, respectively isolated in 1985, 1991 and 1995, were
re-identified by 16SrDNA sequencing. Consequently, M.
canis can be considered as present in France since the
80's without causing any epizootic IBP. Likewise, M.
alkalescens was first isolated in France in 1993 but has
seldom been isolated since then and most often in associ-
ation with M. bovis. This situation contrasts with that
observed in the UK where the proportion of M. alkale-
scens association with IBP increased from nothing to 16%
between 2000 and 2005 [39].
M. leachii, the former M. species bovine serogroup 7
[9], that was associated with serious epizootic outbreaks
of mastitis, arthritis and abortions in Australian cattle
[43] and sporadically isolated from bovine and goats in
Europe [9,44] was not recovered in France during the
2003-2008 period. Several strains isolated from goats
were antigenically similar to PG50, the reference strain of
M. leachii, but proved however to be genetically closer to
Mcc  or  Mmc  [30]. In addition, no "heterologous-host"
reservoir of the CBPP etiological agent was detected by
VIGIMYC.
Contagious agalactia (CA) is still endemic in France
The second major outcome of this study is the confirma-
tion that CA is still widely distributed in France, in con-
trast to the situation in the UK where CA has never been
identified in sheep and goats, despite continuous surveil-
lance [16].
The main etiological agents in goats are mycoplasmas
belonging to the M. mycoides cluster, and primarily Mmc.
Mmc has previously been described as a cause of latent
enzootic infections, with carriage and shedding of multi-
ple strains and sporadic emergence of highly pathogenic
and persistent clones [45]. However, strains isolated from
clinical and normal samples cannot be differentiated by
molecular sub-typing and both have been shown to be
pathogenic under experimental conditions (F. Tardy, per-
sonal communication). Factors triggering the passage
from latent to pathogenic have yet to be identified. None-
theless, because of this situation the economic impact of
caprine CA is probably underestimated in a country that
ranks fifth in world goat milk production [46].
Contrary to the situation in mainland Spain [47], M.
agalactiae is not a major goat pathogen in F rance and
only a few sporadic outbreaks were reported that were
widely distributed across the country. In contrast, forChazel et al. BMC Veterinary Research 2010, 6:32
http://www.biomedcentral.com/1746-6148/6/32
Page 7 of 8
sheep, M. agalactiae remains problematic in the histori-
cally endemic basin of the Western Pyrénées where the
disease reoccurred in 2008 with 98 new outbreaks com-
pared with 33 registered in 2006 (J. Vialard, personal
communication). All these outbreaks might be due to a
single circulating clone that regularly re-emerges (X.
Nouvel, personal communication). In contrast, recent
introduction of the disease into 2 ovine flocks in Corsica
might have resulted from commercial exchange of ani-
mals with Sardinia where ovine CA is still endemic [48].
The present VIGIMYC report also shows that M. agalac-
tiae  might cause pneumonia in the alpine ibex. Fortu-
nately, this enzootic disease occurs only in ibex and no
CA has been detected since 2000 in local domestic goats
despite the possibility of contacts between goats and ibex
in this area.
Conclusions
Overall, the VIGIMYC data show that several major
mycoplasmal diseases of ruminants were documented in
France between 2003 and 2008, but that no major evolu-
tion in epidemiological trends occurred, and notably no
new emergence and no re-emergence of CBPP.
As detailed in a previous study [24], the VIGIMYC sur-
veillance procedures, especially the strain identification
step, encounter several difficulties associated with the
rapidly evolving nature of mycoplasmas [49]. Recent find-
ings, such as genomic plasticity, putative evolution in
quantum leaps, capacity to cross species barriers and
intermediary strains, are modifying our current under-
standing of mycoplasmal diseases, together with their
epidemiology and diagnosis. Future surveillance systems
will no longer be able to rely on etiological diagnosis that
focuses exclusively on currently known pathogenic spe-
cies. A single generic test able to detect and distinguish
any mycoplasmal species from clinical specimens is still
being sought.
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